KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Cash from Investing Activities (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Cash from Investing Activities data on record, last reported at -$209.4 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 83.44% year-over-year to -$209.4 million; the TTM value through Dec 2025 reached $665.8 million, up 120.34%, while the annual FY2025 figure was $665.8 million, 120.34% up from the prior year.
  • Cash from Investing Activities reached -$209.4 million in Q4 2025 per ISRG's latest filing, down from $401.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $574.8 million in Q4 2022 and bottomed at -$1.4 billion in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$202.9 million, with a median of -$212.0 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: crashed 409.82% in 2021, then surged 366.93% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$641.0 million in 2021, then surged by 189.67% to $574.8 million in 2022, then crashed by 281.66% to -$1.0 billion in 2023, then decreased by 21.07% to -$1.3 billion in 2024, then soared by 83.44% to -$209.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$209.4 million in Q4 2025, $401.0 million in Q3 2025, and $260.7 million in Q2 2025.